Synopsis
Join us June 27th at 11am ET (8am PT/ 4pm BST/ 5pm CEST) for an insightful webinar designed for biopharma, academic, and government researchers seeking to reduce drug candidate translational failure and improve disease research.
In the complex landscape of drug discovery and development, the need for more predictive, human-relevant models is paramount. Many researchers are turning to advanced in vitro models like Organ-Chips for deeper insights into disease mechanisms and more accurate assessments of drug safety and efficacy. However, for researchers unfamiliar with advanced cell culture, it can seem daunting to get started.
In this webinar, Luke Dimasi, Senior Director of Product Management at Emulate, will provide an overview of microphysiological systems and explain how Organ-Chips integrate into the drug discovery and development process. Gautam Mahajan, PhD, Emulate Principal Scientific Lead, will present data-driven case studies where Organ-Chips successfully provided researchers with human-relevant insights into inflammatory & infectious disease mechanisms as well as drug candidate safety and efficacy.
Whether you are new to Organ-on-a-Chip technology or looking to deepen your expertise, this webinar will equip you with the knowledge and insights needed to integrate this advanced technology into your research.
In this webinar, you’ll discover:
- An introduction to microphysiological systems (MPS): Understand the use cases, benefits, and differences between spheroids, organoids, and Organ-Chips.
- An overview of the Human Emulation System: See how the different components of Emulate Organ-on-a-Chip technology form a complete, lab-ready solution.
- Endpoint analysis: Learn how to perform rich multi-modal endpoint assessments with Organ-Chips, including imaging, effluent, -omics, and immuno-phenotyping analyses.
- Case studies and success stories: Hear real-world examples of how Organ-Chips have provided more human-relevant insights into disease research and drug development.
